PubMed HealthSearch

Biomedical subjects

D A Long

Publications and source records attributed to D A Long.

12 recordsLinked to original sources

Relative lack of toxicity of transplatin compared with cisplatin in rodents.

The differential toxicity of the cis- and trans-isomers of diamminedichloroplatinum (II) (cisplatin and transplatin) was investigated in rats and guinea pigs. In both species, repeated daily administration of 1 to 2 mg per kg cisplatin produced severe histological and/or functional damage to renal and gastro-intestinal systems and resulted in death of the animals. Quantification of tissue platinum by atomic absorption spectroscopy demonstrated accumulation of large amounts of platinum in the kidney of the animals, with lesser amounts in the liver and gastro-intestinal tract. Transplatin, administered at total doses two- to four-fold that of cisplatin, was essentially non-toxic by histological and functional assessment. However, the amounts of tissue platinum measured in transplatin-treated animals were no smaller than those measured in cisplatin-treated animals; indeed, platinum concentrations in kidneys of transplatin-treated rats were more than 2.5 times those in cisplatin-treated rats. Thus tissue platinum content did not correlate with organ damage. These data suggest that mechanism(s) involving steric interactions of platinum species, perhaps with cellular macromolecules such as DNA or RNA, may be important in the differential toxicity of these two compounds.

Animals

The pH of over-the-counter hydrogen peroxide in soft lens disinfection systems.

We evaluated the pH of six hydrogen peroxide (H2O2) soft lens disinfection systems which had over-the-counter (OTC) H2O2 substituted for the manufacturer's recommended H2O2. Substitution of four brands of OTC H2O2 into the five two-step disinfection systems resulted in a pH after neutralization which ranged from 6.70 to 7.55 pH units. There was a small but statistically significant difference in the pH after neutralization when OTC H2O2 was substituted for the manufacturer's recommended H2O2. There was a significantly lower pH after neutralization when the same brands of OTC H2O2 were substituted for the manufacturer's recommended H2O2 in a one-step H2O2 disinfection system. The pH after neutralization for the manufacturer's recommended H2O2 was 6.50 pH units. The pH after neutralization for the OTC H2O2 ranged from 3.35 to 4.77 pH units. This range is below the ocular comfort range of 6.6 to 7.8 pH units. These findings, along with other possible differences between OTC H2O2 and the manufacturer's recommended H2O2, indicate that OTC H2O2 should never be substituted for the manufacturer's recommended H2O2 in any H2O2 soft lens disinfection system.

Contact Lenses, Hydrophilic

Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure.

In a double-masked, randomized, controlled clinical trial, the authors evaluated the ocular hypotensive efficacy of twice-daily treatment with levobunolol (0.25 and 0.5%) and betaxolol (0.5%) in 85 patients with open-angle glaucoma or ocular hypertension. During the 3-month study, intraocular pressure (IOP) reductions in the two levobunolol groups were significantly greater than in the betaxolol group. From a mean baseline IOP of approximately 25 mmHg, overall mean reductions were 6.2 and 6.0 mmHg for the 0.25 and 0.5% levobunolol groups, respectively, and 3.7 mmHg for the betaxolol group. No clinically or statistically significant among-group differences were noted in the systemic safety variables evaluated. These data suggest that although all three treatments are effective, levobunolol provides a greater reduction in IOP than betaxolol.

Betaxolol

Bilateral dacryops.

The clinical, radiologic, and histopathologic findings of a case of bilateral dacryops is reported in a 49-year-old man. The patient presented with cystic masses located in superior lateral orbits and underwent bilateral excisions of these without any postoperative complications.

Cysts

Equilibration, distribution, and elimination of a single dose of intravenous ethanol in dogs with intact renal function or anuria.

We infused 11 mmol/kg of intravenous ethanol into dogs with either intact renal function (n = 5) or ureteral ligation (n = 7), and studied by frequent blood sampling and by urine collection the time and mode of ethanol equilibration, the elimination parameters, and the comparison of observed equilibrated plasma ethanol levels to levels predicted either by linear or by nonlinear kinetics. Equilibration time was 25 min or less, renal fraction of elimination was less than 5% of total elimination, and both linear (elimination rate) and nonlinear (Vmax and Km) elimination parameters were not different between dogs with intact renal function and dogs with anuria. Serum sodium concentration did not change throughout the experiments, eliminating the hypothesis that acute ethanol load creates clinically significant temporary osmotic water transfer from the intracellular into the extracellular compartment. Distribution volumes of ethanol from linear kinetics were slightly, but not statistically, greater than volumes from nonlinear kinetics. Equilibrated plasma ethanol levels predicted by linear kinetics agreed closely with observed levels greater than 4 mmol/liter, but underestimated observed levels less than 4 mmol/liter. Equilibrated plasma ethanol levels predicted by nonlinear kinetics agreed with observed levels throughout the range of observed concentrations. The use of linear kinetics to predict blood ethanol levels should be limited to the pseudolinear portion of the blood alcohol curve.

Animals

Distribution volume of ethanol as a measure of body water.

We compared the volumes of distribution of intravenous and intragastric ethanol, in a dose of either 7.7 or 11 mmol/kg, to the 3H2O space in anesthetized dogs. The intravenous ethanol space agreed closely with the 3H2O space (y = 0.197 + 0.974x; x axis 3H2O space, r = 0.967, n = 37). After acute saline infusion, changes in both intravenous ethanol and 3H2O spaces reflected accurately the volumes of infused isotonic saline. The determination of intravenous ethanol space could be repeated within 5 h. The intragastric ethanol space overestimated both the 3H2O space and the intravenous ethanol space. Incomplete absorption of ethanol from the gastrointestinal tract was the cause of this observation. In dogs, the intravenous ethanol space provides an accurate measure of body water and of its short changes (a few hours). The intragastric ethanol space overestimates body water in anesthetized dogs because of delayed gastrointestinal absorption.

Animals

Reproducibility of intravenous linear pharmacokinetic parameters of ethanol in dogs.

Linear elimination parameters were computed after intravenous administration of the same dose (11 mmol/kg) of intravenous ethanol in anesthetized dogs twice with a period of 7-8 days (group A, n = 10) or 6 hours (group B, n = 8) between the two studies. For rate of elimination, clearance and time of disappearance of half the dose, routine statistical methods (paired t-test, correlation) showed no difference between the first and the second study of either group; however, for each of these three elimination parameters, quantitative analysis showed significant disparities between the first and second studies of each group. For Widmark ratio r, which is a measurement of ethanol distribution rather than elimination, both the routine statistical methods and the quantitative analysis showed no difference between the first and second study of either group. In dogs, the assumption that blood alcohol curve is reproducible in individuals may not be valid.

Animals

Ethanol elimination in the anesthetized dog: intragastric versus intravenous administration.

We computed by linear kinetics predicted equilibrated plasma concentrations, elimination parameters and availability of ethanol for fasting anesthetized dogs who received the same dose (11 mmol/kg) of ethanol twice, once intragastrically and once intravenously. Agreement between predicted (y) and observed (x) equilibrated plasma levels above 3 mmol/l was for intragastric ethanol y = 0.031 + 1.008x (r = 0.973) and for intravenous ethanol y = 0.2 + 0.99x (r = 0.992). Linear elimination (elimination rate, clearance, time of disappearance of half the dose) was significantly slower and Widmark's ratio r was significantly greater for intragastric than for intravenous ethanol. Apparent availability of intragastric ethanol, computed by dividing the intragastric by the intravenous plasma ethanol concentration at zero time (both values extrapolated from the linear portion of the blood alcohol curve), was 0.739 +/- 0.125. Considerable ethanol residuals were present in the stomach four hours after intragastric instillation. We conclude that retention of ethanol in the stomach, probably because of anesthesia, created the apparent differences in elimination of ethanol between intragastric and intravenous administration. Despite gastric retention, decrease of ethanol levels was linear above 3 mmol/l after intragastric instillation.

Administration, Oral